Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Fidaxomicin Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Fidaxomicin Market Overview

    • 1.1 Product Overview and Scope of Fidaxomicin
    • 1.2 Fidaxomicin Segment by Type
      • 1.2.1 Global Fidaxomicin Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Purity:90%
      • 1.2.3 Purity:95%
      • 1.2.4 Others
    • 1.3 Fidaxomicin Segment by Application
      • 1.3.1 Fidaxomicin Sales Comparison by Application: 2020 VS 2026
      • 1.3.2 Hospital
      • 1.3.3 Retail Pharmacies
    • 1.4 Global Fidaxomicin Market Size Estimates and Forecasts
      • 1.4.1 Global Fidaxomicin Revenue 2015-2026
      • 1.4.2 Global Fidaxomicin Sales 2015-2026
      • 1.4.3 Fidaxomicin Market Size by Region: 2020 Versus 2026

    2 Global Fidaxomicin Market Competition by Manufacturers

    • 2.1 Global Fidaxomicin Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global Fidaxomicin Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global Fidaxomicin Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers Fidaxomicin Manufacturing Sites, Area Served, Product Type
    • 2.5 Fidaxomicin Market Competitive Situation and Trends
      • 2.5.1 Fidaxomicin Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key Fidaxomicin Players (Opinion Leaders)

    3 Fidaxomicin Retrospective Market Scenario by Region

    • 3.1 Global Fidaxomicin Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global Fidaxomicin Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America Fidaxomicin Market Facts & Figures by Country
      • 3.3.1 North America Fidaxomicin Sales by Country
      • 3.3.2 North America Fidaxomicin Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe Fidaxomicin Market Facts & Figures by Country
      • 3.4.1 Europe Fidaxomicin Sales by Country
      • 3.4.2 Europe Fidaxomicin Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Fidaxomicin Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Fidaxomicin Sales by Region
      • 3.5.2 Asia Pacific Fidaxomicin Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America Fidaxomicin Market Facts & Figures by Country
      • 3.6.1 Latin America Fidaxomicin Sales by Country
      • 3.6.2 Latin America Fidaxomicin Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa Fidaxomicin Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Fidaxomicin Sales by Country
      • 3.7.2 Middle East and Africa Fidaxomicin Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global Fidaxomicin Historic Market Analysis by Type

    • 4.1 Global Fidaxomicin Sales Market Share by Type (2015-2020)
    • 4.2 Global Fidaxomicin Revenue Market Share by Type (2015-2020)
    • 4.3 Global Fidaxomicin Price Market Share by Type (2015-2020)
    • 4.4 Global Fidaxomicin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Global Fidaxomicin Historic Market Analysis by Application

    • 5.1 Global Fidaxomicin Sales Market Share by Application (2015-2020)
    • 5.2 Global Fidaxomicin Revenue Market Share by Application (2015-2020)
    • 5.3 Global Fidaxomicin Price by Application (2015-2020)

    6 Company Profiles and Key Figures in Fidaxomicin Business

    • 6.1 Astellas
      • 6.1.1 Corporation Information
      • 6.1.2 Astellas Description, Business Overview and Total Revenue
      • 6.1.3 Astellas Fidaxomicin Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 Astellas Products Offered
      • 6.1.5 Astellas Recent Development
    • 6.2 Merck
      • 6.2.1 Merck Fidaxomicin Production Sites and Area Served
      • 6.2.2 Merck Description, Business Overview and Total Revenue
      • 6.2.3 Merck Fidaxomicin Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 Merck Products Offered
      • 6.2.5 Merck Recent Development

    7 Fidaxomicin Manufacturing Cost Analysis

    • 7.1 Fidaxomicin Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Fidaxomicin
    • 7.4 Fidaxomicin Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Fidaxomicin Distributors List
    • 8.3 Fidaxomicin Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global Fidaxomicin Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Fidaxomicin by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of Fidaxomicin by Type (2021-2026)
    • 10.2 Fidaxomicin Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Fidaxomicin by Application (2021-2026)
      • 10.2.2 Global Forecasted Revenue of Fidaxomicin by Application (2021-2026)
    • 10.3 Fidaxomicin Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Fidaxomicin by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of Fidaxomicin by Region (2021-2026)
    • 10.4 North America Fidaxomicin Estimates and Projections (2021-2026)
    • 10.5 Europe Fidaxomicin Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific Fidaxomicin Estimates and Projections (2021-2026)
    • 10.7 Latin America Fidaxomicin Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa Fidaxomicin Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      This report focuses on Fidaxomicin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fidaxomicin market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
      At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

      The following manufacturers are covered:
      Astellas
      Merck
      ...

      Segment by Regions
      North America
      Europe
      China
      Japan

      Segment by Type
      Purity:90%
      Purity:95%
      Others

      Segment by Application
      Hospital
      Retail Pharmacies
      Buy now